Prognostic Factors and Treatment Strategy in Patients with Hodgkin Lymphoma and HIV Infection Treated with ABVD and CART: A Retrospective Study from Spanish Group Geltamo
María Luisa López Huguet(Universitat Autònoma de Barcelona), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Samuel Romero(Instituto de Investigación Sanitaria La Fe), Ana García‐Noblejas, Mariana Bastos‐Oreiro(Hospital General Universitario Gregorio Marañón), Ramón García‐Sánz(Centro de Investigación del Cáncer), Aleix Méndez López(Institut Català d'Oncologia), Blanca Sánchez‐González(The University of Texas MD Anderson Cancer Center), Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), Juan‐Manuel Sancho(Hospital Universitari Germans Trias i Pujol), Josep‐María Ribera(Universitat Autònoma de Barcelona), Antonio Gutiérrez(Hospital Universitario Son Dureta), María-Jesús Vidal-Manceñido(Hospital de León), Paola Villafuerte Gutiérrez(Hospital Universitario Príncipe de Asturias)
Cited by 1
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
|The Lancet Oncology|2009|511
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493